Acceder

MARIA DEL CARMEN ASENSIO LOPEZ

Buscador

Asensio Lopez MDC, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes Genis A, Pascual Figal DA. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Aug 11;10(1):13553. doi: 10.1038/s41598-020-70454-8. PubMed PMID: 32782412; PubMed Central PMCID: PMC7419540.
AÑO: 2020; IF: 3.998
Asensio-Lopez MC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Januzzi JL, Bayes-Genis A, Pascual-Figal DA. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction. J Mol Cell Cardiol. 2019 May;130:216-233. doi: 10.1016/j.yjmcc.2019.04.009. Epub 2019 Apr 15. PubMed PMID: 30998979.
AÑO: 2019; IF: 5.055
Sánchez-Más J, Saura-Guillén E, Asensio-López MC, Soriano-Filiu Á, Carmen Sánchez-Pérez M, Hernandez-Martinez AM, Lax A, Pascual-Figal D. Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction. Diabetes Metab. 2019 Apr;45(2):201-204. doi: 10.1016/j.diabet.2017.09.008. Epub 2017 Oct 31. PubMed PMID: 29097004.
AÑO: 2019; IF: 4.008
Sanchez-Serna J, Martinez-Villanueva M, Hernández-Vicente Á, Asensio-Lopez MC, Noguera JA, Pascual-Figal DA. Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure. Rev Clin Esp. 2019 Aug - Sep;219(6):315-319. doi: 10.1016/j.rce.2018.10.004. Epub 2019 Feb 6. English, Spanish. PubMed PMID: 30737010.
AÑO: 2019; IF: 1.043
Pascual-Figal DA, Bayes-Genis A, Asensio-Lopez MC, Hernández-Vicente A, Garrido-Bravo I, Pastor-Perez F, Díez J, Ibáñez B, Lax A. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure. J Am Coll Cardiol. 2019 Mar 12;73(9):1016-1025. doi: 10.1016/j.jacc.2018.11.054. PubMed PMID: 30846095.
AÑO: 2019; IF: 18.639

Instituto de Investigación Sanitaria Acreditado

ISCII